Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
Advances in Anatomic Pathology|August 13, 2023
The Significance of Recognition of Human Epidermal Growth Factor 2 Low in Breast Cancer TherapyGary TozbikianAnnals of Diagnostic Pathology|March 8, 2008
Signet ring cell gastric schwannoma: report of a new distinctive morphological variantGary Tozbikian, Rulong Shen, Saul SusterJournal of Pathology and Translational Medicine|May 18, 2022
What's new in breast pathology 2022: WHO 5th edition and biomarker updatesKristen Muller, Julie M Jorns, Gary TozbikianDiagnostic Pathology|June 30, 2019
Diagnostic terminology used to describe atypia on breast core needle biopsy: correlation with excision and upgrade ratesGary Tozbikian, Michael George, Debra L ZyngerThe Breast Journal|March 17, 2017
Specimen Identification Errors in Breast Biopsies: Age Matters. Report of Two Near-Miss Events and Review of the LiteratureGary Tozbikian, Mary L Gemignani, Edi BrogiUrology Case Reports|May 9, 2022
Anastomosing hemangioma: A case report of a benign tumor often misdiagnosed as a malignant epithelioid angiosarcomaNada Shaker, Ankush Patel, Gary Tozbikian, et al.Clinical Case Reports|December 20, 2018
Concurrent phyllodes tumor, eccrine carcinoma, and multinodular goiter 20 years after radiotherapy for Hodgkin lymphomaKristen M Quinn, Gary Tozbikian, William E CarsonAmerican Journal of Clinical Pathology|April 28, 2017
Using the Modified Magee Equation to Identify Patients Unlikely to Benefit From the 21-Gene Recurrence Score Assay (Oncotype DX Assay)Yanjun Hou, Gary Tozbikian, Debra L Zynger, et al.Human Pathology|January 3, 2017
Breast cancer biomarkers before and after neoadjuvant chemotherapy: does repeat testing impact therapeutic management?Zhaoying Xian, Alexander K Quinones, Gary Tozbikian, et al.Radiology Case Reports|March 14, 2023
Masson's tumor of the reconstructed breastIan Klonk, Stephen P Povoski, Gary Tozbikian, et al.Pageof 4